REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

JENNISON ASSOCIATES LLC's Holding History (CIK: 0000053417)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 1,032,352 Value ($000) $9,074 Avg Close — Range —
Q3 2023
Shares 997,616 Value ($000) $11,443 Avg Close — Range —
Q2 2023
Shares 1,839,267 Value ($000) $46,552 Avg Close — Range —
Q1 2023
Shares 1,633,305 Value ($000) $52,609 Avg Close — Range —
Q4 2022
Shares 2,026,025 Value ($000) $37,400 Avg Close — Range —
Q3 2022
Shares 1,072,235 Value ($000) $28,950 Avg Close — Range —
Q2 2022
Shares 1,755,703 Value ($000) $24,264 Avg Close — Range —
Q1 2022
Shares 2,441,286 Value ($000) $47,605 Avg Close — Range —
Q4 2021
Shares 2,203,564 Value ($000) $35,962 Avg Close — Range —
Q3 2021
Shares 2,085,526 Value ($000) $58,103 Avg Close — Range —
Q2 2021
Shares 1,942,580 Value ($000) $57,578 Avg Close — Range —
Q1 2021
Shares 2,100,983 Value ($000) $58,722 Avg Close — Range —
Q4 2020
Shares 2,201,508 Value ($000) $62,391 Avg Close — Range —
Q3 2020
Shares 2,286,042 Value ($000) $57,471 Avg Close — Range —
Q2 2020
Shares 2,126,541 Value ($000) $51,930 Avg Close — Range —
Q1 2020
Shares 1,702,524 Value ($000) $25,197 Avg Close — Range —
Q3 2018
Shares 34,753 Value ($000) $864 Avg Close — Range —
Q2 2018
Shares 1,131,960 Value ($000) $31,072 Avg Close — Range —
Q1 2018
Shares 1,483,037 Value ($000) $45,678 Avg Close — Range —
Q4 2017
Shares 857,536 Value ($000) $30,657 Avg Close — Range —
Q3 2017
Shares 377,528 Value ($000) $10,401 Avg Close — Range —
Q2 2017
Shares 378,400 Value ($000) $9,990 Avg Close — Range —
Q3 2015
Shares 78,156 Value ($000) $2,326 Avg Close — Range —
Q2 2015
Shares 77,553 Value ($000) $2,480 Avg Close — Range —
Q1 2015
Shares 109,367 Value ($000) $2,267 Avg Close — Range —
Q4 2014
Shares 109,125 Value ($000) $1,849 Avg Close — Range —
Q3 2014
Shares 299,194 Value ($000) $5,783 Avg Close — Range —
Q2 2014
Shares 1,121,134 Value ($000) $38,119 Avg Close — Range —
Q1 2014
Shares 174,972 Value ($000) $5,512 Avg Close — Range —